BMS settles claims with states in probe connected to Plavix deal
This article was originally published in Scrip
Executive Summary
Bristol-Myers Squibbwill pay $1.1 million to settle anticompetitive claims by state attorney generals that the company violated 2003 court orders in two earlier lawsuits.